113
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

An Evaluation of a Bayesian Method of Dose Escalation Based on Bivariate Binary Responses

, , &
Pages 969-983 | Received 01 Mar 2004, Accepted 01 Mar 2004, Published online: 02 Feb 2007

References

  • Babb , J. , Rogatko , A. and Zacks , S. 1998 . Cancer phase I clinical trials: Efficient dose escalation with overdose control . Statist. Med. , 17 : 1103 – 1120 .
  • Braun , T. M. 2002 . The bivariate continual reassessment method: Extending the CRM to phase I trials of two competing outcomes . Control. Clin. Trials , 23 : 240 – 256 .
  • Faries , D. 1994 . Practical modifications of the continual reassessment method for phase I cancer clinical trials . J. Biopharmaceutical Statist. , 4 : 147 – 164 .
  • Gasparini , M. and Eisele , J. 2000 . A curve-free method for phase I clinical trials . Biometrics , 56 : 609 – 615 .
  • Goodman , S. N. , Zahurak , M. L. and Piantadosi , S. 1995 . Some practical improvements in the continual reassessment method for phase I studies . Statist. Med. , 14 : 1149 – 1161 .
  • Gooley , T. A. , Martin , P. J. , Fisher , L. D. and Pettinger , M. 1994 . Simulation as a design tool for phase I/II clinical trials: An example from bone-marrow transplantation . Control. Clin. Trials , 15 : 450 – 462 .
  • Korn , E. L. , Midthune , D. , Chen , T. T. , Rubinstein , L. V. , Christian , M. C. and Simon , R. M. 1994 . A comparison of two phase I designs . Statist. Med. , 13 : 1799 – 1806 .
  • O'Quigley , J. 2001 . “ Dose-finding designs using continual reassessment method ” . In Statistics in Clinical Oncology Edited by: Crowley , J. 35 – 72 . New York : Dekker .
  • O'Quigley , J. , Pepe , M. and Fisher , L. 1990 . Continual reassessment method: A practical design for phase I clinical trials in cancer . Biometrics , 46 : 33 – 48 .
  • O'Quigley , J. , Hughes , M. D. and Fenton , T. 2001 . Dose-finding designs for HIV studies . Biometrics , 57 : 1018 – 1029 .
  • Rosenberger , W. F. and Haines , L. M. 2002 . Competing designs for phase I clinical trials: A review . Statist. Med. , 21 : 2757 – 2770 .
  • Thall , P. F. and Russell , K. E. 1998 . A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials . Biometrics , 54 : 251 – 264 .
  • Whitehead , J. and Brunier , H. 1995 . Bayesian decision procedures for dose determining experiments . Statist. Med. , 14 : 885 – 893 .
  • Whitehead , J. and Williamson , D. 1998 . An evaluation of Bayesian decision procedures for dose-finding studies . J. Biopharmaceutical Statist. , 8 : 445 – 467 .
  • Whitehead , J. , Zhou , Y. , Stevens , J. , Blakey , G. , Price , J. and Leadbetter , J. 2004 . Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit. Technical Report 04/3, School of Applied Statistics, University of Reading .
  • Zhou , Y. and Whitehead , J. 2003 . Practical implementation of Bayesian dose escalation procedures . Drug Inf. J. , 37 : 45 – 59 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.